Wednesday, March 3, 2021

Survival

Impact of the COVID-19 Pandemic on Ovarian Cancer Management: Adapting to the New Normal

The Gynecologic Oncology Institute focuses on ovarian cancer and supports all efforts to get care back to normal as soon as possible.  This is another form of collateral damage due to the pandemic and it certainly hits our patients close to home. Cancer Manag Res. 2021, Jan. 14; 13: 359-366. doi: 10.2147 / CMAR.S287152. eCollection […]

Ovarian Cancer Patients Live Eight Years Longer: Molecular Profiling Impact

The following is a press release from Caris Life Sciences about a breakthrough presentation of data at the recent American Society for Clinical Oncology (ASCO) meeting. In this study, the median overall survival was eight years longer in ovarian and fallopian tube cancer patients treated using Caris Molecular Intelligence profiling vs. those who did not....

Read More

Most Read